TLPH News and Press, Talphera Inc. From 10/21/25

Talphera Announces the Appointment of Joe Todisco to Board of Directors PR Newswire SAN MATEO, Calif. , Oct. 21, 2025 /PRNewswire/ -- Talphera, Inc. (Nasdaq: TLPH), (Talphera), a specialty pharmaceutical company focused on the development and commercialization of innovat...

2025-09-22 17:18:48 ET More on Talphera Talphera, Inc. (TLPH) Q2 2025 Earnings Call Transcript Talphera announces private placement financing of up to $29M priced at-the market Talphera outlines accelerated NEPHRO enrollment and lowers 2025 cash operating expense gui...

2025-09-08 11:55:27 ET DENVER, Colo., Sep 08, 2025 ( 247marketnews.com )- Today’s market is teeming with momentum across SaaS pivots, digital disruptors, biotech breakthroughs, and green energy bets. Here’s what’s making waves this morning: TEN Holdings (N...

2025-09-08 08:49:22 ET More on CorMedix, Talphera CorMedix: The Undervalued Breakthrough Talphera outlines accelerated NEPHRO enrollment and lowers 2025 cash operating expense guidance amid protocol shift CorMedix slides after pricing $85M stock offering Re...

BERKELEY HEIGHTS, N.J., Sept. 08, 2025 (GLOBE NEWSWIRE) -- CorMedix Inc. (“CorMedix”) (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced that it has made a $5 millio...

Talphera Announces Private Placement Financing of up to $29 Million Priced At-the Market PR Newswire CorMedix is making a strategic investment in Talphera as the lead investor, supported by existing stockholders Nantahala, Rosalind and Rock Springs with several new institution...

Talphera Announces Achievement of 17 Patient Enrollment Milestone in NEPHRO CRRT Pivotal Trial PR Newswire The NEPHRO CRRT pivotal trial has now reached approximately 25% enrollment, driven by the recent acceleration in the recruitment rate from new profile clinical sites ...

2025-08-14 21:11:22 ET More on Talphera Talphera, Inc. (TLPH) Q2 2025 Earnings Call Transcript Seeking Alpha’s Quant Rating on Talphera Historical earnings data for Talphera Financial information for Talphera Read the full article on Seeking ...

2025-08-14 21:10:33 ET Talphera, Inc. (TLPH) Q2 2025 Earnings Conference Call August 14, 2025, 4:30 PM ET Company Participants Raffi Mark Asadorian - Chief Financial Officer Shakil Aslam - Chief Medical Officer Vincent J. Angotti - CEO & Director Confer...

2025-08-14 16:06:55 ET More on Talphera Seeking Alpha’s Quant Rating on Talphera Historical earnings data for Talphera Financial information for Talphera Read the full article on Seeking Alpha For further details see: Talphera GAAP EPS of -...